Everolimus-Eluting Versus Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention

Kyung Woo Park, MD,* In-Ho Chae, MD,† Do-Sun Lim, MD,‡ Kyoo-Rok Han, MD,§ Han-Mo Yang, MD,* Hae-Young Lee, MD,* Hyun-Jae Kang, MD,* Bon-Kwon Koo, MD,* Taehoon Ahn, MD, Jung-Han Yoon, MD,¶ Myung-Ho Jeong, MD,# Taek-Jong Hong, MD,** Woo-Young Chung, MD,†† Sang-Ho Jo, MD,‡‡ Young-Jin Choi, MD,‡‡ Seung-Ho Hur, MD,§§ Hyuck-Moon Kwon, MD, Dong-Woon Jeon, MD,¶¶ Byung-Ok Kim, MD,## Si-Hoon Park, MD,*** Nam-Ho Lee, MD,††† Hui-Kyung Jeon, MD,‡‡‡ Hyeon-Cheol Gwon, MD,§§§ Yang-Soo Jang, MD, Hyo-Soo Kim, MD* Seoul, Sungnam, Incheon, Wonju, Gwangju, Busan, Pyungchon, Daegu, Ilsan, and Uijeongbu, Korea